The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
Author:
Affiliation:
1. Tokyo Japan
2. Ogaki Japan
3. Takamatsu Japan
4. Fukuoka Japan
5. Kawasaki Japan
6. Matsuyama Japan
7. Inashiki Japan
8. Yokohama Japan
9. Sagamihara Japan
10. Osaka Japan
11. Izunokuni Japan
12. Matsudo Japan
13. Nagoya Japan
14. Sapporo Japan
15. Suita Japan
16. Kashiwa Japan
17. Ishinomaki Japan
18. Iwaki Japan
Funder
Nippon Medical School
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15218/fullpdf
Reference47 articles.
1. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection;Satapathy;Hepatol Int,2012
2. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease;Tsui;Arch Intern Med,2007
3. Hepatitis C infection is very rarely treated among hemodialysis patients;Goodkin;Am J Nephrol,2013
4. Epidemiological survey of patients with hemodialysis complicated by hepatitis C in Japan;Okubo;Ther Apher Dial,2018
5. Hepatitis C virus and death risk in hemodialysis patients;Kalantar-Zadeh;J Am Soc Nephrol,2007
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12
2. ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis;Journal of Gastroenterology;2024-05-10
3. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma;Biomarkers;2024-02-15
4. Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital;Saudi Medical Journal;2024-01
5. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma;Journal of Pharmaceutical and Biomedical Analysis;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3